TickerFacts.

Anika Therapeutics, Inc. (ANIK): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$11.19M
Year ended 2025-12-31
$5.98M
Trailing 12 months to 2026-06-30
+36.4%
3-year compound annual growth
-3.1%
5-year compound annual growth
-11.9%
10-year compound annual growth
$40.81M2009-12-31: $3.09M2010-12-31: $7.85M2011-12-31: $10.17M2012-12-31: $10.55M2013-12-31: $25.16M2014-12-31: $39.98M2015-12-31: $39.91M2016-12-31: $24.45M2017-12-31: $40.81M2018-12-31: $34.92M2019-12-31: $37.01M2020-12-31: $13.06M2021-12-31: $8.40M2022-12-31: $4.41M2023-12-31: -$1.79M2024-12-31: $5.40M2025-12-31: $11.19M$11.19M
2009-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$11.19M+107.1%2026-03-03, From 2025-01-01
2024-12-31$5.40Mn/m2026-03-03, From 2024-01-01
2023-12-31-$1.79Mn/m2026-03-03, From 2023-01-01
2022-12-31$4.41M-47.5%2025-03-17, From 2022-01-01
2021-12-31$8.40M-35.7%2024-03-15, From 2021-01-01
2020-12-31$13.06M-64.7%2023-03-16, From 2020-01-01
2019-12-31$37.01M+6.0%2022-03-11, From 2019-01-01
2018-12-31$34.92M-14.4%2021-04-26, From 2018-01-01
2017-12-31$40.81M+66.9%2020-03-06, From 2017-01-01
2016-12-31$24.45M-38.7%2019-02-27, From 2016-01-01
2015-12-31$39.91Mn/c2018-02-27, From 2015-01-01
2014-12-31$39.98M+58.9%2017-02-24, From 2014-01-01
2013-12-31$25.16M+138.6%2016-03-10, From 2013-01-01
2012-12-31$10.55M+3.7%2014-03-13, From 2012-01-01
2011-12-31$10.17M+29.5%2014-03-13, From 2011-01-01
2010-12-31$7.85M+153.8%2013-03-14, From 2010-01-01
2009-12-31$3.09Mn/a2012-03-13, From 2009-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Anika Therapeutics, Inc. (ANIK)2025-12-31$11.19M+107.1%
Orasure Technologies Inc (OSUR)2025-12-31-$49.02Mn/m
Beta Bionics, Inc. (BBNX)2025-12-31-$50.92Mn/m
NeuroPace Inc (NPCE)2025-12-31-$11.01Mn/m
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30-$81.70Mn/m
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$12.55Mn/m
Pulmonx Corp (LUNG)2025-12-31-$32.38Mn/m
InfuSystem Holdings, Inc (INFU)2025-12-31$24.41M+19.3%
Neuronetics, Inc. (STIM)2025-12-31-$20.37Mn/m

Compare ANIK, OSUR, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗